HEADER TRANSFERASE 31-MAR-21 7O2V TITLE AURORA KINASE A IN COMPLEX WITH THE AUR-A/PDK1 INHIBITOR VI8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AURORA KINASE A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AURORA 2,AURORA/IPL1-RELATED KINASE 1,ARK-1,AURORA-RELATED COMPND 5 KINASE 1,HARK1,BREAST TUMOR-AMPLIFIED KINASE,SERINE/THREONINE-PROTEIN COMPND 6 KINASE 15,SERINE/THREONINE-PROTEIN KINASE 6,SERINE/THREONINE-PROTEIN COMPND 7 KINASE AURORA-A; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS SERINE/THREONINE, KINASE, AURORA, INHIBITOR, CRYSTAL, COMPLEX, KEYWDS 2 CANCER, TUMOR, DUAL, ATP-BINDING, STRUCTURE-BASED, DRUG DESIGN, KEYWDS 3 SBDD, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.GARAU REVDAT 2 31-JAN-24 7O2V 1 REMARK REVDAT 1 20-OCT-21 7O2V 0 JRNL AUTH S.SESTITO,A.BACCI,S.CHIARUGI,M.RUNFOLA,F.GADO,E.MARGHERITIS, JRNL AUTH 2 S.GUL,M.E.RIVEIRO,R.VAZQUEZ,S.HUGUET,C.MANERA,K.REZAI, JRNL AUTH 3 G.GARAU,S.RAPPOSELLI JRNL TITL DEVELOPMENT OF POTENT DUAL PDK1/AURA KINASE INHIBITORS FOR JRNL TITL 2 CANCER THERAPY: LEAD-OPTIMIZATION, STRUCTURAL INSIGHTS, AND JRNL TITL 3 ADME-TOX PROFILE. JRNL REF EUR.J.MED.CHEM. V. 226 13895 2021 JRNL REFN ISSN 0223-5234 JRNL PMID 34624821 JRNL DOI 10.1016/J.EJMECH.2021.113895 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.SIMONA DANIELE,S.SESTITO,D.PIETROBONO,C.GIACOMELLI, REMARK 1 AUTH 2 G.CHIELLINI,D.DI MAIO,L.MARINELLI,E.NOVELLINO,C.MARTINI, REMARK 1 AUTH 3 S.RAPPOSELLI REMARK 1 TITL DUAL INHIBITION OF PDK1 AND AURORA KINASE A: AN EFFECTIVE REMARK 1 TITL 2 STRATEGY TO INDUCE DIFFERENTIATION AND APOPTOSIS OF HUMAN REMARK 1 TITL 3 GLIOBLASTOMA MULTIFORME STEM CELLS REMARK 1 REF ACS CHEM. NEUROSCI. V. 8 100 2016 REMARK 1 REFN ESSN 1948-7193 REMARK 1 PMID 27797168 REMARK 1 DOI 10.1021/ACSCHEMNEURO.6B00251 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.13 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 6224 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.275 REMARK 3 R VALUE (WORKING SET) : 0.272 REMARK 3 FREE R VALUE : 0.329 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.380 REMARK 3 FREE R VALUE TEST SET COUNT : 335 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.1300 - 3.9000 1.00 3172 174 0.2390 0.3012 REMARK 3 2 3.3100 - 3.1000 0.91 2717 161 0.3737 0.4123 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.598 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 36.504 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 95.77 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 112.5 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2277 REMARK 3 ANGLE : 1.238 3075 REMARK 3 CHIRALITY : 0.061 321 REMARK 3 PLANARITY : 0.007 391 REMARK 3 DIHEDRAL : 11.381 297 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -15.6484 -31.9694 8.4320 REMARK 3 T TENSOR REMARK 3 T11: 0.9194 T22: 0.7938 REMARK 3 T33: 0.6436 T12: 0.2434 REMARK 3 T13: 0.1158 T23: -0.0753 REMARK 3 L TENSOR REMARK 3 L11: 8.7197 L22: 4.9067 REMARK 3 L33: 1.5155 L12: 2.1032 REMARK 3 L13: 1.8003 L23: -0.1022 REMARK 3 S TENSOR REMARK 3 S11: -0.5327 S12: -1.2862 S13: 1.0702 REMARK 3 S21: 0.5132 S22: 0.3599 S23: 0.2252 REMARK 3 S31: -0.2791 S32: -0.4988 S33: 0.1841 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7O2V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-APR-21. REMARK 100 THE DEPOSITION ID IS D_1292115028. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 11.2C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97850 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6602 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 71.130 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 31.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.25 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3FDN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M HEPES PH 7.5, 0.2 M (NH4)2SO4, REMARK 280 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.43067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 110.86133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 83.14600 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 138.57667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 27.71533 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 55.43067 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 110.86133 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 138.57667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 83.14600 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 27.71533 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 619 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 105 REMARK 465 HIS A 106 REMARK 465 HIS A 107 REMARK 465 HIS A 108 REMARK 465 HIS A 109 REMARK 465 HIS A 110 REMARK 465 HIS A 111 REMARK 465 HIS A 112 REMARK 465 HIS A 113 REMARK 465 HIS A 114 REMARK 465 HIS A 115 REMARK 465 SER A 116 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 GLN A 402 REMARK 465 SER A 403 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 120 -87.08 -68.24 REMARK 500 ASP A 202 -157.04 -121.48 REMARK 500 SER A 226 -50.49 71.13 REMARK 500 VAL A 252 79.74 -110.86 REMARK 500 ARG A 255 -153.11 -72.32 REMARK 500 SER A 388 42.42 -90.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue V0K A 501 DBREF 7O2V A 116 403 UNP O14965 AURKA_HUMAN 116 403 SEQADV 7O2V SER A 105 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 106 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 107 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 108 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 109 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 110 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 111 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 112 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 113 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 114 UNP O14965 EXPRESSION TAG SEQADV 7O2V HIS A 115 UNP O14965 EXPRESSION TAG SEQRES 1 A 299 SER HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS SER LYS SEQRES 2 A 299 GLN LYS ASN GLU GLU SER LYS LYS ARG GLN TRP ALA LEU SEQRES 3 A 299 GLU ASP PHE GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS SEQRES 4 A 299 PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN SER LYS SEQRES 5 A 299 PHE ILE LEU ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU SEQRES 6 A 299 GLU LYS ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL SEQRES 7 A 299 GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG SEQRES 8 A 299 LEU TYR GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU SEQRES 9 A 299 ILE LEU GLU TYR ALA PRO LEU GLY THR VAL TYR ARG GLU SEQRES 10 A 299 LEU GLN LYS LEU SER LYS PHE ASP GLU GLN ARG THR ALA SEQRES 11 A 299 THR TYR ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS SEQRES 12 A 299 HIS SER LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU SEQRES 13 A 299 ASN LEU LEU LEU GLY SER ALA GLY GLU LEU LYS ILE ALA SEQRES 14 A 299 ASP PHE GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG SEQRES 15 A 299 THR THR LEU CYS GLY THR LEU ASP TYR LEU PRO PRO GLU SEQRES 16 A 299 MET ILE GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU SEQRES 17 A 299 TRP SER LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY SEQRES 18 A 299 LYS PRO PRO PHE GLU ALA ASN THR TYR GLN GLU THR TYR SEQRES 19 A 299 LYS ARG ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE SEQRES 20 A 299 VAL THR GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU SEQRES 21 A 299 LYS HIS ASN PRO SER GLN ARG PRO MET LEU ARG GLU VAL SEQRES 22 A 299 LEU GLU HIS PRO TRP ILE THR ALA ASN SER SER LYS PRO SEQRES 23 A 299 SER ASN CYS GLN ASN LYS GLU SER ALA SER LYS GLN SER HET V0K A 501 72 HETNAM V0K 1-[[3,4-BIS(FLUORANYL)PHENYL]METHYL]-~{N}-[(1~{R})-2- HETNAM 2 V0K [[(3~{E})-3-(1~{H}-IMIDAZOL-5-YLMETHYLIDENE)-2- HETNAM 3 V0K OXIDANYLIDENE-1~{H}-INDOL-5-YL]AMINO]-2-OXIDANYLIDENE- HETNAM 4 V0K 1-PHENYL-ETHYL]-6-METHYL-2-OXIDANYLIDENE-PYRIDINE-3- HETNAM 5 V0K CARBOXAMIDE FORMUL 2 V0K C34 H26 F2 N6 O4 FORMUL 3 HOH *19(H2 O) HELIX 1 AA1 ALA A 129 GLU A 131 5 3 HELIX 2 AA2 LYS A 166 GLY A 173 1 8 HELIX 3 AA3 VAL A 174 SER A 186 1 13 HELIX 4 AA4 VAL A 218 SER A 226 1 9 HELIX 5 AA5 ASP A 229 LYS A 250 1 22 HELIX 6 AA6 LYS A 258 GLU A 260 5 3 HELIX 7 AA7 PRO A 297 GLU A 302 1 6 HELIX 8 AA8 GLU A 308 GLY A 325 1 18 HELIX 9 AA9 THR A 333 VAL A 344 1 12 HELIX 10 AB1 THR A 353 LEU A 364 1 12 HELIX 11 AB2 ASN A 367 ARG A 371 5 5 HELIX 12 AB3 MET A 373 HIS A 380 1 8 HELIX 13 AB4 HIS A 380 SER A 387 1 8 SHEET 1 AA1 5 PHE A 133 LYS A 141 0 SHEET 2 AA1 5 GLY A 145 GLU A 152 -1 O LEU A 149 N GLY A 136 SHEET 3 AA1 5 ILE A 158 PHE A 165 -1 O VAL A 163 N ASN A 146 SHEET 4 AA1 5 ARG A 205 LEU A 210 -1 O LEU A 210 N ALA A 160 SHEET 5 AA1 5 LEU A 196 HIS A 201 -1 N PHE A 200 O TYR A 207 SHEET 1 AA2 3 GLY A 216 THR A 217 0 SHEET 2 AA2 3 LEU A 262 LEU A 264 -1 O LEU A 264 N GLY A 216 SHEET 3 AA2 3 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SITE 1 AC1 12 LEU A 139 GLY A 140 LYS A 143 GLY A 145 SITE 2 AC1 12 LYS A 162 ALA A 213 GLY A 216 THR A 217 SITE 3 AC1 12 LYS A 258 ASN A 261 LEU A 263 GLY A 291 CRYST1 82.129 82.129 166.292 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012176 0.007030 0.000000 0.00000 SCALE2 0.000000 0.014060 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006014 0.00000